Oncology

A Wealth of Experience

We have collaborated with our clients on projects to research cancer, cancer treatment, and complications and comorbidities of cancer. Our experience includes:

  • Basal cell carcinoma
  • Bladder cancer
  • Breast cancer
  • Cervical cancer
  • Colorectal cancer
  • Endometrial cancer
  • Gastric cancer
  • Glioblastoma multiforme
  • Head and neck cancer
  • Large B-cell lymphoma
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Melanoma
  • Myelofibrosis
  • Neuroendocrine tumors
  • Non-Hodgkin’s lymphoma
  • Renal cell carcinoma
  • Osteosarcoma
  • Ovarian cancer
  • Pancreatic cancer
  • Peritoneal cancers
  • Prostate cancer
  • Thyroid cancer

Types of Projects

We have implemented studies to help our clients develop strategies in the oncology market and to develop and gain 
market access for products to treat cancer and complications arising from treatment of cancer illnesses. 

Recent projects have included:

Our Experts

Christopher Graham
Senior Director, Health Economics
Colleen Castro
Associate, Market Access and Outcomes Strategy
Katherine Hicks
Director, Health Economics
Dee Dee Mladsi
Head, Health Economics-Strategy and Early Modeling
Brett Hauber
Senior Economist and VP, Health Preference Assessment
Bintu Sherif
Senior Statistician
Elizabeth Andrews
Vice President, Pharmacoepidemiology and Risk Management
Stephanie Barrows
Senior Director, Market Access and Outcomes Strategy
Marci Clark
Director, Patient-Centered Outcomes Assessment
Ann Colosia
Associate Director, Market Access and Outcomes Strategy
Alicia Gilsenan
Senior Director, Epidemiology
Will Herring
Director, Health Economics
Jin Yang
Sr. Associate, Market Access and Outcomes Strategy
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Michele Wilson
Director, Health Economics
Joan Fortuny
Senior Research Epidemiologist
Jonathan Graham
Director, Health Economics
Anne Heyes
Head, Market Access and Outcomes Strategy, Europe
Xiaolei Zhou
Director, Biostatistics, US
Costel Chirila
Director, Biostatistics
Laurel Trantham
Associate Director, Health Economics
Isobel Pearson
Director, Health Economics
Kenneth Rothman
Distinguished Fellow, Vice President of Epidemiology Research
Sorrel Wolowacz
Head, European Health Economics
Caroline Ling
Senior Director, Market Access and Outcomes Strategy
Melissa Juniper
Senior Director, Market Access and Outcomes Strategy
Christopher Knight
Senior Director, Health Economics
Kelly Hollis
Global Head, Surveys and Observational Studies
James Kaye
Senior Director, Epidemiology
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Marco Boeri
Senior Research Economist
Beth Sherrill
Vice President, Biostatistics
Shaun Abeysinghe
Senior Director, Data Analytics and Design Strategy
Ewa Rupniewska
Senior Associate, Market Access and Outcomes Strategy
Jianmin Wang
Director, Biostatistics, US
Susan Hogue
Head, Value Insight and Access Strategy
Katherine Houghton
Associate Director, Health Economics
Sean Candrilli
Head, Health Economics
Anita Brogan
Head, Decision Analytic Modeling, US Health Economics
Carol Mansfield
Senior Research Economist
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Jessica Costello
Writer, Market Access and Outcomes Strategy
Keith Davis
Senior Director, Health Economics
Juliana Meyers
Director, Health Economics
Christine Poulos
Senior Research Economist
Ryan Ziemiecki
Senior Statistician
Shahnaz Khan
Senior Director, Market Access and Outcomes Strategy
Lia Gutierrez
Director, Epidemiology
Mark Price
Senior Director, Surveys and Observational Studies
Lori McLeod
Head, Psychometrics & Executive Director, Patient-Centered Outcomes Assessment
Dawn Odom
Global Head, Biostatistics
Donald Stull
Head, Data Analytics and Design Strategy
Annete Njue
Director, Market Access and Outcomes Strategy

Selected Recent Oncology Publications